Daftar pustaka


Ngugi AK, Kariuki SM, Bottomley C, Kleinschmidt I, Sander JW, Newton CR: Incidence of epilepsy: a systematic review and meta-analysis. Neurology 2011, 77:1005–1012.

2. Schuele SU, Luders HO: Intractable epilepsy: management and therapeutic alternatives. Lancet Neurol 2008, 7:514–524. 3. Kwan P, Sander JW: The natural history of epilepsy: an epidemiological view. J Neurol Neurosurg Psychiatry 2004, 75:1376–1381. 4. Hui AC, Wong A, Wong HC, Man BL, Au-Yeung KM, Wong KS: Refractory epilepsy in a Chinese population. Clin Neurol Neurosurg 2007, 109:672–675. 5. Hitiris N, Mohanraj R, Norrie J, Sills GJ, Brodie MJ: Predictors of pharmacoresistant epilepsy. Epilepsy Res 2007, 75:192–196. 6. Oskoui M, Webster RI, Zhang X, Shevell MI: Factors predictive of outcome in childhood epilepsy. J Child Neurol 2005, 20:898–904. 7. Arts WF, Brouwer OF, Peters AC, Stroink H, Peeters EA, Schmitz PI, van Donselaar CA, Geerts AT: Course and prognosis of childhood epilepsy: 5year follow-up of the Dutch study of epilepsy in childhood. Brain 2004, 127:1774–1784. 8. Choi H, Heiman GA, Munger Clary H, Etienne M, Resor SR, Hauser WA: Seizure remission in adults with long-standing intractable epilepsy: an extended follow-up. Epilepsy Res 2011, 93:115–119.


13. Sander JW: The prevalence and treatment gap in epilepsy in China: an ILAE/IBE/WHO study. Pollard J. Scott RA. Lee P. de Boer HM. 2005– 2009. 14. Genton P. Moshe SL. Perucca E. Rodemer W. Mathern GW. Berg AT. Epilepsia 2010. Berg AT. Wu JZ. Kwan P. Callaghan B. Arzimanoglou A. 22:489–501. Wang DS. Neurology 2003.9. et al: Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology. Mathern G. French J: Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the 13 . Proposal for revised clinical and electroencephalographic classification of epileptic seizures: From the Commission on Classification and Terminology of the International League Against Epilepsy. Hesdorffer D. Allen Hauser W. 60:1544–1545. Cross JH. Allen Hauser W. Yang B. Yuan CL. 46:470–472. Wiebe S. 11. Fisher RS. Brodie MJ. 10. Wang TP. Epilepsia 2005. Brodie MJ. French J. French J: Remission and relapse in a drug-resistant epilepsy population followed prospectively. Glauser TA. Blume W. Engel J Jr: Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Elger C. Engel J. Buchhalter J. van Emde BW. Epilepsia 2011. Berkovic SF. van Emde BW. Schlesinger M. Epilepsia 1981. 12. Prilipko LL. Wang WZ. Dai XY. 51:676–685. 52:619–626.

Langan Y. 15. 51:1069– 1077. Sillanpaa M. 20. 19.ILAE Commission on Therapeutic Strategies. Norrie JD. 16. 46:858–877. Mohanraj R. Bamagous GA. Eur J Neurol 2006. Brain 2006. Schmidt D: Natural history of treated childhood-onset epilepsy: prospective. Loscher W: Drug resistance in epilepsy: putative neurobiologic and clinical mechanisms. Nashef L. Neurology 2005. Barry SJ. 17. Camfield PR. Dooley JM: If a first antiepileptic drug fails to control a child’s epilepsy. Sander JW: Case–control study of SUDEP. Kwan P: Patterns of treatment response in newly diagnosed epilepsy. 131:821–824. Camfield CS. Epilepsia 2010. 78:1548–1554. long-term population-based study. 14 . Epilepsia 2005. Gordon K. 64:1131–1133. Neurology 2012. Brodie MJ: Diagnosing refractory epilepsy: response to sequential treatment schedules. 18. 13:277–282. what are the chances of success with the next drug? J Pediatr 1997. Brodie MJ. 129:617–624. Schmidt D.